Northern Trust Corp Reduces Stock Holdings in Danaher Corporation $DHR

Key Points

• Northern Trust Corp reduced its stake in Danaher Corporation by 2.2% during Q1, selling 172,252 shares, leaving it with 7,762,739 shares valued at approximately $1.59 billion.
• Institutional investors collectively own 79.05% of Danaher's stock, with notable increases from firms like Invesco Ltd. (44.5% increase) and Vanguard Group Inc. (0.4% increase).
• Danaher reported earnings of $1.80 per share in its latest quarterly results, surpassing analysts' expectations of $1.64, with a total revenue of $5.94 billion for the quarter.

Northern Trust Corp decreased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 2.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,762,739 shares of the conglomerate's stock after selling 172,252 shares during the quarter. Northern Trust Corp owned about 1.08% of Danaher worth $1,591,361,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of DHR. GHP Investment Advisors Inc. boosted its position in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter valued at about $27,000. Sierra Ocean LLC boosted its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher during the 1st quarter valued at about $31,000. Finally, Dunhill Financial LLC boosted its position in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on DHR shares. Evercore ISI lowered their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. UBS Group decreased their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a research report on Friday, July 11th. Argus decreased their target price on shares of Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Finally, Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Stock Down 3.4%

Shares of DHR stock traded down $7.2480 during trading hours on Thursday, reaching $204.1520. 3,172,582 shares of the stock were exchanged, compared to its average volume of 4,228,694. The business's fifty day moving average is $200.46 and its two-hundred day moving average is $199.62. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The firm has a market capitalization of $146.18 billion, a P/E ratio of 43.44, a P/E/G ratio of 2.96 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the firm earned $1.72 earnings per share. The business's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.